Unresolved disorder model. using A ATOM 111 N AGLY 15 0.792 16.677 -20.443 0.50 51.76 N Unresolved disorder model. using A ATOM 112 N BGLY 15 0.929 16.682 -20.441 0.50 51.56 N Unresolved disorder model. using A ATOM 113 CA AGLY 15 0.295 15.310 -20.643 0.50 51.80 C Unresolved disorder model. using A ATOM 114 CA BGLY 15 0.914 15.239 -20.627 0.50 51.43 C Unresolved disorder model. using A ATOM 115 C AGLY 15 1.051 14.241 -19.863 0.50 51.84 C Unresolved disorder model. using A ATOM 116 C BGLY 15 1.587 14.605 -19.423 0.50 51.26 C Unresolved disorder model. using A ATOM 117 O AGLY 15 2.006 13.658 -20.375 0.50 51.91 O Unresolved disorder model. using A ATOM 118 O BGLY 15 2.474 15.195 -18.808 0.50 51.37 O Unresolved disorder model. using A ATOM 119 N ATHR 16 0.620 13.973 -18.629 0.50 51.89 N Unresolved disorder model. using A ATOM 120 N BTHR 16 1.164 13.393 -19.097 0.50 51.22 N Unresolved disorder model. using A ATOM 121 CA ATHR 16 1.223 12.913 -17.810 0.50 51.83 C Unresolved disorder model. using A ATOM 122 CA BTHR 16 1.570 12.711 -17.878 0.50 51.11 C Unresolved disorder model. using A ATOM 123 C ATHR 16 0.899 11.528 -18.381 0.50 51.63 C Unresolved disorder model. using A ATOM 124 C BTHR 16 0.391 11.797 -17.641 0.50 50.89 C Unresolved disorder model. using A ATOM 125 O ATHR 16 1.781 10.819 -18.878 0.50 51.60 O Unresolved disorder model. using A ATOM 126 O BTHR 16 0.528 10.649 -17.210 0.50 51.02 O Unresolved disorder model. using A ATOM 127 CB ATHR 16 0.745 12.971 -16.328 0.50 51.91 C Unresolved disorder model. using A ATOM 128 CB BTHR 16 1.703 13.682 -16.693 0.50 51.23 C Unresolved disorder model. using A ATOM 129 OG1ATHR 16 0.923 14.306 -15.815 0.50 52.49 O Unresolved disorder model. using A ATOM 130 OG1BTHR 16 1.894 15.021 -17.175 0.50 51.34 O Unresolved disorder model. using A ATOM 131 CG2ATHR 16 1.544 11.988 -15.470 0.50 51.97 C Unresolved disorder model. using A ATOM 132 CG2BTHR 16 2.874 13.283 -15.797 0.50 51.21 C Unresolved disorder model. using A ATOM 133 N ATYR 17 -0.375 11.150 -18.299 0.50 51.32 N Unresolved disorder model. using A ATOM 134 N BTYR 17 -0.779 12.360 -17.940 0.50 50.55 N Unresolved disorder model. using A ATOM 135 CA ATYR 17 -0.826 9.885 -18.858 0.50 50.84 C Unresolved disorder model. using A ATOM 136 CA BTYR 17 -2.001 11.609 -18.190 0.50 50.15 C Unresolved disorder model. using A ATOM 137 C ATYR 17 -1.269 10.025 -20.315 0.50 50.38 C Unresolved disorder model. using A ATOM 138 C BTYR 17 -1.957 11.091 -19.623 0.50 49.57 C Unresolved disorder model. using A ATOM 139 O ATYR 17 -1.901 9.121 -20.880 0.50 50.42 O Unresolved disorder model. using A ATOM 140 O BTYR 17 -2.353 9.959 -19.904 0.50 49.54 O Unresolved disorder model. using A ATOM 141 CB ATYR 17 -1.920 9.250 -17.984 0.50 51.12 C Unresolved disorder model. using A ATOM 142 CB BTYR 17 -3.193 12.556 -18.063 0.50 50.27 C Unresolved disorder model. using A ATOM 143 CG ATYR 17 -1.358 8.447 -16.828 0.50 51.63 C Unresolved disorder model. using A ATOM 144 CG BTYR 17 -2.945 13.885 -18.746 0.50 50.38 C Unresolved disorder model. using A ATOM 145 CD1ATYR 17 -0.884 7.150 -17.025 0.50 51.82 C Unresolved disorder model. using A ATOM 146 CD1BTYR 17 -3.002 13.999 -20.138 0.50 50.53 C Unresolved disorder model. using A ATOM 147 CD2ATYR 17 -1.278 8.992 -15.542 0.50 51.88 C Unresolved disorder model. using A ATOM 148 CD2BTYR 17 -2.624 15.023 -18.004 0.50 50.76 C Unresolved disorder model. using A ATOM 149 CE1ATYR 17 -0.358 6.408 -15.972 0.50 52.04 C Unresolved disorder model. using A ATOM 150 CE1BTYR 17 -2.763 15.210 -20.769 0.50 50.68 C Unresolved disorder model. using A ATOM 151 CE2ATYR 17 -0.752 8.256 -14.479 0.50 51.76 C Unresolved disorder model. using A ATOM 152 CE2BTYR 17 -2.381 16.239 -18.628 0.50 50.98 C Unresolved disorder model. using A ATOM 153 CZ ATYR 17 -0.292 6.966 -14.703 0.50 51.75 C Unresolved disorder model. using A ATOM 154 CZ BTYR 17 -2.452 16.323 -20.010 0.50 50.69 C Unresolved disorder model. using A ATOM 155 OH ATYR 17 0.234 6.222 -13.666 0.50 52.14 O Unresolved disorder model. using A ATOM 156 OH BTYR 17 -2.217 17.521 -20.636 0.50 50.98 O Unresolved disorder model. using A ATOM 157 N AGLY 18 -0.915 11.152 -20.933 0.50 49.52 N Unresolved disorder model. using A ATOM 158 N BGLY 18 -1.488 11.953 -20.525 0.50 48.98 N Unresolved disorder model. using A ATOM 159 CA AGLY 18 -1.114 11.289 -22.370 0.50 48.44 C Unresolved disorder model. using A ATOM 160 CA BGLY 18 -1.434 11.660 -21.959 0.50 48.18 C Unresolved disorder model. using A ATOM 161 C AGLY 18 -1.086 12.677 -22.992 0.50 47.65 C Unresolved disorder model. using A ATOM 162 C BGLY 18 -1.379 12.916 -22.825 0.50 47.41 C Unresolved disorder model. using A ATOM 163 O AGLY 18 -0.411 13.591 -22.514 0.50 47.61 O Unresolved disorder model. using A ATOM 164 O BGLY 18 -0.912 13.966 -22.378 0.50 47.33 O Unresolved disorder model. using A ATOM 478 CA AASN 59 -22.095 20.358 -15.127 0.50 30.55 C Unresolved disorder model. using A ATOM 479 CA BASN 59 -22.100 20.359 -15.128 0.50 30.35 C Unresolved disorder model. using A ATOM 482 CB AASN 59 -23.393 19.769 -15.697 0.50 31.41 C Unresolved disorder model. using A ATOM 483 CB BASN 59 -23.411 19.780 -15.688 0.50 31.02 C Unresolved disorder model. using A ATOM 484 CG AASN 59 -23.550 20.040 -17.182 0.50 33.07 C Unresolved disorder model. using A ATOM 485 CG BASN 59 -23.271 18.341 -16.164 0.50 31.84 C Unresolved disorder model. using A ATOM 486 OD1AASN 59 -24.450 20.775 -17.603 0.50 36.50 O Unresolved disorder model. using A ATOM 487 OD1BASN 59 -24.110 17.499 -15.851 0.50 35.15 O Unresolved disorder model. using A ATOM 488 ND2AASN 59 -22.658 19.459 -17.990 0.50 35.74 N Unresolved disorder model. using A ATOM 489 ND2BASN 59 -22.219 18.055 -16.926 0.50 32.48 N Unresolved disorder model. using A ATOM 1443 CA ACYS 177 -1.655 19.620 8.782 0.50 32.96 C Unresolved disorder model. using A ATOM 1444 CA BCYS 177 -1.638 19.608 8.796 0.50 33.08 C Unresolved disorder model. using A ATOM 1447 CB ACYS 177 -2.651 20.759 8.560 0.50 32.87 C Unresolved disorder model. using A ATOM 1448 CB BCYS 177 -2.605 20.779 8.651 0.50 33.04 C Unresolved disorder model. using A ATOM 1449 SG ACYS 177 -4.209 20.532 9.444 0.50 34.82 S Unresolved disorder model. using A ATOM 1450 SG BCYS 177 -1.975 22.281 9.424 0.50 35.71 S Unresolved disorder model. using A ATOM 1676 CA AASP 206 11.676 26.539 -5.432 0.70 26.48 C Unresolved disorder model. using A ATOM 1677 CA BASP 206 11.659 26.546 -5.438 0.30 25.63 C Unresolved disorder model. using A ATOM 1680 CB AASP 206 13.059 26.892 -5.988 0.70 27.81 C Unresolved disorder model. using A ATOM 1681 CB BASP 206 13.017 26.946 -6.013 0.30 25.97 C Unresolved disorder model. using A ATOM 1682 CG AASP 206 13.954 27.593 -4.977 0.70 30.40 C Unresolved disorder model. using A ATOM 1683 CG BASP 206 12.894 28.002 -7.103 0.30 25.46 C Unresolved disorder model. using A ATOM 1684 OD1AASP 206 13.878 27.293 -3.766 0.70 34.79 O Unresolved disorder model. using A ATOM 1685 OD1BASP 206 12.065 27.822 -8.020 0.30 25.77 O Unresolved disorder model. using A ATOM 1686 OD2AASP 206 14.761 28.448 -5.409 0.70 34.44 O Unresolved disorder model. using A ATOM 1687 OD2BASP 206 13.621 29.013 -7.044 0.30 25.83 O Unresolved disorder model. using A ATOM 2502 CA AHIS 307 -22.375 20.934 4.365 0.60 21.87 C Unresolved disorder model. using A ATOM 2503 CA BHIS 307 -22.329 20.855 4.227 0.40 21.28 C Unresolved disorder model. using A ATOM 2506 CB AHIS 307 -22.374 21.207 5.876 0.60 22.23 C Unresolved disorder model. using A ATOM 2507 CB BHIS 307 -22.006 20.622 5.715 0.40 21.16 C Unresolved disorder model. using A ATOM 2508 CG AHIS 307 -22.690 20.019 6.727 0.60 23.89 C Unresolved disorder model. using A ATOM 2509 CG BHIS 307 -22.897 21.362 6.661 0.40 20.80 C Unresolved disorder model. using A ATOM 2510 ND1AHIS 307 -22.253 19.913 8.030 0.60 26.15 N Unresolved disorder model. using A ATOM 2511 ND1BHIS 307 -22.555 22.581 7.204 0.40 20.53 N Unresolved disorder model. using A ATOM 2512 CD2AHIS 307 -23.396 18.889 6.475 0.60 26.33 C Unresolved disorder model. using A ATOM 2513 CD2BHIS 307 -24.113 21.051 7.170 0.40 19.78 C Unresolved disorder model. using A ATOM 2514 CE1AHIS 307 -22.676 18.772 8.543 0.60 25.39 C Unresolved disorder model. using A ATOM 2515 CE1BHIS 307 -23.525 22.993 8.000 0.40 20.25 C Unresolved disorder model. using A ATOM 2516 NE2AHIS 307 -23.377 18.135 7.623 0.60 26.46 N Unresolved disorder model. using A ATOM 2517 NE2BHIS 307 -24.485 22.087 7.992 0.40 21.09 N Unresolved disorder model. using A ATOM 3355 CA AASP 411 -5.605 -17.319 -4.228 0.60 53.12 C Unresolved disorder model. using A ATOM 3356 CA BASP 411 -5.584 -17.300 -4.235 0.40 52.85 C Unresolved disorder model. using A ATOM 3359 CB AASP 411 -6.454 -18.334 -3.426 0.60 53.31 C Unresolved disorder model. using A ATOM 3360 CB BASP 411 -6.367 -18.307 -3.375 0.40 52.83 C Unresolved disorder model. using A ATOM 3361 CG AASP 411 -5.645 -19.542 -2.921 0.60 54.27 C Unresolved disorder model. using A ATOM 3362 CG BASP 411 -6.448 -17.889 -1.909 0.40 52.73 C Unresolved disorder model. using A ATOM 3363 OD1AASP 411 -4.392 -19.522 -2.956 0.60 55.55 O Unresolved disorder model. using A ATOM 3364 OD1BASP 411 -5.441 -17.381 -1.366 0.40 52.15 O Unresolved disorder model. using A ATOM 3365 OD2AASP 411 -6.280 -20.526 -2.476 0.60 54.69 O Unresolved disorder model. using A ATOM 3366 OD2BASP 411 -7.520 -18.074 -1.296 0.40 52.92 O Unresolved disorder model. using A ATOM 4170 CA AGLU 513 -41.387 6.692 12.634 0.50 37.88 C Unresolved disorder model. using A ATOM 4171 CA BGLU 513 -41.427 6.768 12.600 0.50 37.82 C Unresolved disorder model. using A ATOM 4174 CB AGLU 513 -42.734 7.426 12.699 0.50 38.39 C Unresolved disorder model. using A ATOM 4175 CB BGLU 513 -42.629 7.726 12.512 0.50 37.95 C Unresolved disorder model. using A ATOM 4176 CG AGLU 513 -43.946 6.580 12.260 0.50 40.44 C Unresolved disorder model. using A ATOM 4177 CG BGLU 513 -43.635 7.424 11.392 0.50 38.50 C Unresolved disorder model. using A ATOM 4178 CD AGLU 513 -44.080 5.240 12.995 0.50 42.95 C Unresolved disorder model. using A ATOM 4179 CD BGLU 513 -44.807 8.398 11.351 0.50 39.03 C Unresolved disorder model. using A ATOM 4180 OE1AGLU 513 -43.800 5.168 14.217 0.50 43.76 O Unresolved disorder model. using A ATOM 4181 OE1BGLU 513 -44.840 9.358 12.154 0.50 40.95 O Unresolved disorder model. using A ATOM 4182 OE2AGLU 513 -44.488 4.253 12.340 0.50 44.12 O Unresolved disorder model. using A ATOM 4183 OE2BGLU 513 -45.705 8.199 10.506 0.50 41.09 O Unresolved disorder model. using A ATOM 4746 CA AARG 584 -20.667 -16.645 -23.961 0.70 36.20 C Unresolved disorder model. using A ATOM 4747 CA BARG 584 -20.634 -16.672 -23.961 0.30 35.28 C Unresolved disorder model. using A ATOM 4750 CB AARG 584 -20.078 -17.942 -23.388 0.70 36.32 C Unresolved disorder model. using A ATOM 4751 CB BARG 584 -19.952 -17.959 -23.487 0.30 35.40 C Unresolved disorder model. using A ATOM 4752 CG AARG 584 -18.572 -18.073 -23.531 0.70 37.72 C Unresolved disorder model. using A ATOM 4753 CG BARG 584 -19.389 -17.939 -22.062 0.30 34.95 C Unresolved disorder model. using A ATOM 4754 CD AARG 584 -17.973 -19.154 -22.617 0.70 38.31 C Unresolved disorder model. using A ATOM 4755 CD BARG 584 -19.096 -19.351 -21.531 0.30 35.03 C Unresolved disorder model. using A ATOM 4756 NE AARG 584 -16.650 -18.728 -22.151 0.70 42.35 N Unresolved disorder model. using A ATOM 4757 NE BARG 584 -18.860 -20.330 -22.595 0.30 34.31 N Unresolved disorder model. using A ATOM 4758 CZ AARG 584 -15.516 -18.887 -22.831 0.70 43.19 C Unresolved disorder model. using A ATOM 4759 CZ BARG 584 -19.691 -21.323 -22.908 0.30 34.46 C Unresolved disorder model. using A ATOM 4760 NH1AARG 584 -15.516 -19.495 -24.015 0.70 43.77 N Unresolved disorder model. using A ATOM 4761 NH1BARG 584 -20.822 -21.497 -22.231 0.30 34.25 N Unresolved disorder model. using A ATOM 4762 NH2AARG 584 -14.373 -18.441 -22.316 0.70 44.68 N Unresolved disorder model. using A ATOM 4763 NH2BARG 584 -19.385 -22.153 -23.897 0.30 34.39 N Unresolved disorder model. using A ATOM 7591 CA AGLU 936 -35.375 6.025 -49.804 0.60 35.62 C Unresolved disorder model. using A ATOM 7592 CA BGLU 936 -35.376 6.020 -49.799 0.40 35.15 C Unresolved disorder model. using A ATOM 7595 CB AGLU 936 -34.997 5.325 -51.119 0.60 35.95 C Unresolved disorder model. using A ATOM 7596 CB BGLU 936 -34.992 5.322 -51.113 0.40 35.57 C Unresolved disorder model. using A ATOM 7597 CG AGLU 936 -34.692 6.247 -52.305 0.60 36.57 C Unresolved disorder model. using A ATOM 7598 CG BGLU 936 -35.770 4.033 -51.419 0.40 35.95 C Unresolved disorder model. using A ATOM 7599 CD AGLU 936 -34.675 5.503 -53.636 0.60 37.33 C Unresolved disorder model. using A ATOM 7600 CD BGLU 936 -35.237 2.801 -50.689 0.40 37.30 C Unresolved disorder model. using A ATOM 7601 OE1AGLU 936 -35.317 4.430 -53.729 0.60 39.67 O Unresolved disorder model. using A ATOM 7602 OE1BGLU 936 -35.285 2.756 -49.438 0.40 37.56 O Unresolved disorder model. using A ATOM 7603 OE2AGLU 936 -34.023 5.992 -54.589 0.60 39.40 O Unresolved disorder model. using A ATOM 7604 OE2BGLU 936 -34.790 1.855 -51.371 0.40 38.14 O 1